|
1 Indications And Usage Saxenda Is Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adult Patients With An Initial Body Mass Index (Bmi) Of • 30 Kg/m 2 Or Greater (Obesity), Or • 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight-Related Comorbid Condition (E.g., Hypertension, Type 2 Diabetes Mellitus, Or Dyslipidemia) Limitations Of Use • Saxenda Is Not Indicated For The Treatment Of Type 2 Diabetes Mellitus. • Saxenda And Victoza ® Both Contain The Same Active Ingredient, Liraglutide, And Therefore Should Not Be Used Together. Saxenda Should Not Be Used In Combination With Any Other Glp-1 Receptor Agonist. • The Safety And Effectiveness Of Saxenda In Combination With Other Products Intended For Weight Loss, Including Prescription Drugs, Over-The-Counter Drugs, And Herbal Preparations, Have Not Been Established. Saxenda Is A Glucagon-Like Peptide-1 (Glp-1) Receptor Agonist Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adult Patients With An Initial Body Mass Index (Bmi) Of • 30 Kg/m 2 Or Greater (Obesity) ( 1 ) Or • 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight-Related Comorbid Condition (E.g. Hypertension, Type 2 Diabetes Mellitus, Or Dyslipidemia) ( 1 ). Limitations Of Use: • Saxenda Is Not Indicated For The Treatment Of Type 2 Diabetes ( 1 ). • Saxenda Should Not Be Used In Combination With Any Other Glp-1 Receptor Agonist ( 1 ). • The Safety And Efficacy Of Coadministration With Other Products For Weight Loss Have Not Been Established (1).
|